TW218880B - - Google Patents

Download PDF

Info

Publication number
TW218880B
TW218880B TW081104188A TW81104188A TW218880B TW 218880 B TW218880 B TW 218880B TW 081104188 A TW081104188 A TW 081104188A TW 81104188 A TW81104188 A TW 81104188A TW 218880 B TW218880 B TW 218880B
Authority
TW
Taiwan
Prior art keywords
isopropylidene
quot
page
propylamine
ministry
Prior art date
Application number
TW081104188A
Other languages
English (en)
Chinese (zh)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of TW218880B publication Critical patent/TW218880B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
TW081104188A 1991-05-30 1992-05-27 TW218880B (OSRAM)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70750591A 1991-05-30 1991-05-30

Publications (1)

Publication Number Publication Date
TW218880B true TW218880B (OSRAM) 1994-01-11

Family

ID=24841976

Family Applications (1)

Application Number Title Priority Date Filing Date
TW081104188A TW218880B (OSRAM) 1991-05-30 1992-05-27

Country Status (14)

Country Link
EP (1) EP0516154A1 (OSRAM)
JP (1) JPH05148291A (OSRAM)
KR (1) KR920021574A (OSRAM)
AU (1) AU655025B2 (OSRAM)
CA (1) CA2069714A1 (OSRAM)
CS (1) CS158992A3 (OSRAM)
FI (1) FI922444A7 (OSRAM)
HU (1) HU210492B (OSRAM)
IE (1) IE921763A1 (OSRAM)
IL (1) IL101997A0 (OSRAM)
MX (1) MX9202572A (OSRAM)
OA (1) OA09750A (OSRAM)
TW (1) TW218880B (OSRAM)
ZA (1) ZA923815B (OSRAM)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518589A (en) * 1983-10-03 1985-05-21 Bristol-Myers Company BBM-2478 Antibiotic complex
NZ211872A (en) * 1984-04-27 1989-06-28 Ishihara Sangyo Kaisha Chartreusin derivatives and antitumorous compositions
EP0219852B1 (en) * 1985-10-23 1992-02-05 Ishihara Sangyo Kaisha, Ltd. Chartreusin derivatives, salts thereof, antitumorous compositions containing the same, and processes for producing the same
DK0381114T3 (da) * 1989-01-30 1994-10-24 Ishihara Sangyo Kaisha Exo-3,4-O-benzyliden-3"-demethylchartreusin og salte deraf

Also Published As

Publication number Publication date
HUT62306A (en) 1993-04-28
FI922444L (fi) 1992-12-01
JPH05148291A (ja) 1993-06-15
AU655025B2 (en) 1994-12-01
OA09750A (en) 1993-11-30
AU1724292A (en) 1992-12-10
MX9202572A (es) 1993-01-01
IE921763A1 (en) 1992-12-02
HU9201731D0 (en) 1992-08-28
CA2069714A1 (en) 1992-12-01
EP0516154A1 (en) 1992-12-02
FI922444A7 (fi) 1992-12-01
ZA923815B (en) 1993-02-24
KR920021574A (ko) 1992-12-18
CS158992A3 (en) 1992-12-16
HU210492B (en) 1995-04-28
FI922444A0 (fi) 1992-05-27
IL101997A0 (en) 1992-12-30

Similar Documents

Publication Publication Date Title
KR101679362B1 (ko) 테트라사이클린 화합물의 염 및 다형체
PH12012500168B1 (en) Crystalline solvates and complexes of (is)-1,5-anhydro-l-c-(3-((phenyl)methyl)phenyl)-d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes
PL96677B1 (pl) Sposob wytwarzania nowych zwiazkow tetracyklinowych
WO2008038965A1 (en) 7alpha-aminosteroid derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for anticancer or antibiotics containing the same as an active ingredient
EP3838901B1 (en) Compound for treatment of rabies and method for treatment of rabies
DE69925472T2 (de) Benzoheterocyclische distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel
TW201011034A (en) New (poly) aminoalkylaminoalkylamide, alkyl-urea, or alkyl-sulfonamide derivatives of epipodophyllotoxin, a process for preparing them, and application thereof in therapy as anticancer agents
US20080058391A1 (en) Novel compounds
IE52717B1 (en) Novel indanyl derivatives and their manufacture and use
DE69707098T2 (de) Substituierte tetralylmethylenoxindol-analoga als tyrosinkinase-inhibitoren
SU993822A3 (ru) Способ получени гликозидов антрациклина
TW218880B (OSRAM)
AU2020213989B2 (en) Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound
JP5958948B1 (ja) ｐ２１活性化キナーゼ阻害剤
CN107778336A (zh) 吡喃葡萄糖基衍生物的结晶形式
WO2017025031A1 (zh) 一种抗病毒活性双氮氧杂环螺二酮哌嗪生物碱衍生物及其制备方法
US4275192A (en) Bis(4-demethoxydaunorubicin)dihydrazone derivatives and pharmacologically acceptable salts thereof
Yancheva et al. Synthesis, Crystal Structure and Biological Activity Screening of Novel N-(α-Bromoacyl)-α-amino Esters Containing Valyl Moiety.
RU2120444C1 (ru) Способ получения изепамицина и промежуточные соединения
CN120390741A (zh) 制备氨基甲酸酯衍生物的方法
JPH09501412A (ja) ラベンダマイシン類縁体、それらの使用及び調製
Rhee et al. Synthesis of cyclopenin and glycosminine from phenylpyruvic acid
CN106632405B (zh) 一种鬼臼毒素与去甲斑蝥素的拼合物及其制备与应用
CA3127469C (en) Polymorphic forms of a substituted-quinoxaline-type bridged-piperidine compound
CA2014925A1 (fr) Derives macrolides, leur procede de preparation et les compositions pharmaceutiques qui les contiennent